Precision targeting tumor cells using cancer-specific InDel mutations with CRISPR-Cas9.
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9):e2103532119. doi: 10.1073/pnas.2103532119.
Proc Natl Acad Sci U S A. 2022.
PMID: 35217600
Free PMC article.